- Home
- CVAC vs IAUX Comparison
CVAC vs IAUX Comparison
Compare CVAC & IAUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CVAC | IAUX |
|---|---|---|
| Founded | 2000 | 2020 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVAC | IAUX |
|---|---|---|
| Price | $4.66 | $1.53 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $6.83 | $1.50 |
| AVG Volume (30 Days) | 1.3M | ★ 8.1M |
| Earning Date | 11-24-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.02 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | $83,000,117.00 | ★ $97,131,000.00 |
| Revenue This Year | N/A | $85.81 |
| Revenue Next Year | $23.71 | $97.70 |
| P/E Ratio | $4.98 | ★ N/A |
| Revenue Growth | N/A | ★ 83.46 |
| 52 Week Low | $2.48 | $0.48 |
| 52 Week High | $5.72 | $1.60 |
Technical Indicators
Market Signals| Indicator | CVAC | IAUX |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | 62.91 |
| Support Level | $4.26 | $1.43 |
| Resistance Level | $4.68 | $1.57 |
| Average True Range (ATR) | 0.17 | 0.09 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 62.56 | 57.14 |
Price Performance
Historical ComparisonAbout CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About IAUX i-80 Gold Corp.
i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.